Uterine Inertia

11/01/2011 - "There was a significant reduction in the rate of subsequent manual removal of placenta (30 vs. 67.7%, p < 0.05), incidence of uterine atony (3.3 vs. 25.8%, p < 0.05) and the need for uterotonic agents (33.3 vs. 64.5%, p < 0.05) in the oxytocin group when compared with the control group. "
10/01/2009 - "In cases in which postpartum haemorrhage was due to uterine atony, 83.1% of women underwent examination of the uterine cavity and 96.3% received oxytocin, which proved therapeutic. "
07/01/2013 - "We conducted a secondary analysis of a 3-arm double-blind randomized trial of different dose regimens of oxytocin to prevent uterine atony after vaginal delivery. "
06/01/2011 - "Recent studies suggest that the effective dose of oxytocin for prophylaxis against uterine atony during caesarean delivery is significantly lower than the 5-10 IU historically used by anaesthesiologists. "
06/01/2010 - "This study was designed to determine the effective dose (ED)(90) of oxytocin infusion for an elective Cesarean delivery (CD) to prevent uterine atony. "

01/01/2000 - "Misoprostol in uterine atony: a report of 2 cases."
05/01/2005 - "The purpose of this study was to assess the efficacy of buccal misoprostol to decrease uterine atony, hemorrhage, and the need for additional uterotonic agents during cesarean delivery. "
10/01/2001 - "These preliminary findings are encouraging and suggest that further investigations would be useful to assess the beneficial effect of misoprostol by rectal administration for patients with severe delivery-induced hemorrhage due to uterine atony. "
04/01/2010 - "To compare the efficacy of rectally administered misoprostol with intravenous oxytocin infusion in preventing uterine atony and blood loss during cesarean delivery. "
02/01/2006 - "To compare the effectiveness of sublingual misoprostol administered immediately after delivery of the neonate at cesarean section, with intravenous oxytocin infusion in prevention of uterine atony and thereby reducing blood loss at cesarean section. "

05/01/2006 - "Additional intramyometrial prostaglandin F2alpha (PGF2alpha) was administered when obstetrician diagnosed uterine atony. "
04/01/2006 - "Prostaglandin F2alpha: French guidelines for uterine atony management."
02/01/2004 - "PGF2alpha and its analogs are useful for treating uterine atony that does not respond to other drugs, but side effects are not unknown. "
09/01/1988 - "Maternal arterial desaturation with 15-methyl prostaglandin F2 alpha for uterine atony."
05/01/1977 - "[Treatment of primary uterine inertia with prostaglandin F2-alpha]."

10/01/1983 - "Control of persistent primary postpartum haemorrhage due to uterine atony with intravenous prostaglandin E2. "
03/01/1983 - "Control of persistent primary postpartum haemorrhage due to uterine atony with intravenous prostaglandin E2. "
10/01/1990 - "Treatment of postpartum haemorrhage because of uterine atony with intramyometrial prostaglandin E2 1 mg, in an anaesthetised patient resulted in life-threatening hypotension. "
07/01/1980 - "Prostaglandin E2 vaginal suppositories may be useful in the treatment of persistent postpartum uterine atony."
07/01/1980 - "This case of postpartum uterine atony, with several features suggesting persistent myometrial dysfunction which did not respond to usual medical measures, responded to treatment with intravaginal prostaglandin E2 (PGE2) suppositories. "

07/01/1980 - "Prostaglandin E2 vaginal suppositories may be useful in the treatment of persistent postpartum uterine atony."
07/01/1980 - "This case of postpartum uterine atony, with several features suggesting persistent myometrial dysfunction which did not respond to usual medical measures, responded to treatment with intravaginal prostaglandin E2 (PGE2) suppositories. "
07/01/1980 - "Treatment of postpartum uterine atony with prostaglandin E2 vaginal suppositories."
06/01/1983 - "Prostaglandin E2 vaginal suppositories have been described as effective in arresting immediate postpartum hemorrhage secondary to uterine atony. "

12/01/2010 - "[Use of carbetocin in prevention of uterine atony during cesarean section. "
11/01/2009 - "Carbetocin is currently indicated for prevention of uterine atony after delivery by caesarean section in spinal or epidural anaesthesia. "
09/01/2013 - "Oxytocin is the first-line treatment for uterine atony, although the effects of the long-acting oxytocin analogue carbetocin are comparable with that of oxytocin. "
06/01/2013 - "Compared with oxytocin, prophylaxis of uterine atony with carbetocin after an elective CS diminished the need for additional uterotonics by more than 50 %."
12/01/2010 - "Prevention of uterine atony during a caesarian section with carbetocin seems to be as effective as oxytocin. "

11/01/2011 - "For only uterine atony (n=71), there was a slight improvement in the prescription of sulprostone within 30 minutes (53 and 58%), and improved decision within 2 hours (47 and 69%). "
10/01/2004 - "We report an analytical study over a period of 18 months and gathering 60 cases of haemorrhage of the delivery by uterine inertia having imposed the recourse to the sulprostone. "
06/01/2008 - "Only two patients had uterine atony, and inefficiency of sulprostone was observed in all patients. "
10/01/2004 - "[Sulprostone in the treatment of uterine inertia. "
01/01/2005 - "[Anaphylactic shock and uterine atony: must we use sulprostone]."

11/01/1956 - "[Estrogens and their importance in uterine inertia]."
06/01/2006 - "Estrogen shows cooperative efficacy with uterotonics in stimulating uterine contraction for managements of postpartum hemorrhage due to uterine atony, and can be of value in clinical application."
06/01/2006 - "To investigate the clinical efficacy of estrogen in management of postpartum hemorrhage due to uterine atony. "

04/01/2011 - "Postpartum hemorrhage from uterine atony, and cervical and vaginal lacerations were treated successfully with 1-desamino-8D-arginine vasopressin and blood products. "

09/01/2012 - "Preoperative administration of sublingual misoprostol 400μg is safe and effective in attenuating the maternal bleeding and uterine atony from isoflurane anesthesia for cesarean delivery."

03/01/2011 - "This newly modified anchor B-Lynch compression suture appeared effective in controlling about 75% of PPH due to uterine atony, which allowed uterine conservation. "
07/01/2012 - "This is a descriptive study including 39 patients treated with the B-Lynch suture after postpartum haemorrhage related to uterine atony. "
07/01/2009 - "Our study reviews the cases in which the B-Lynch suture was used to treat uterine atony, and the clinical outcomes of these cases. "
08/01/2015 - "[Modified technique b-lynch compression suture with uterine atony]."
05/01/2015 - "A total of 36 women who were managed with the B-Lynch suture, with or without additional surgical procedures following uterine atony unresponsive to medical treatment, were evaluated retrospectively. "

05/19/1979 - "Radiological checks in 116 Black primigravid patients with dysfunctional labour demonstrated that an active trial of labour is accurate in determining which of these patients have marked disproportion requiring caesarean section, minimal disproportion requiring assisted delivery, or primary uterine inertia responding to oxytocic stimulation. "
11/01/2014 - "Uterine atony during first stage cesarean section and unintentional uterine incision extensions during second stage cesarean section were significantly more frequent when the operation was performed for non-progressive labor."
12/01/2013 - "Most had a cesarean section, with uterine atony as the most common indication for EPH. "
01/01/2013 - "The indications were ruptured uterus (61.8%), intractable haemorrhage during caesarean section (32.4%), and uterine atony (5.9%). "
02/01/2012 - "Furthermore, the incidence of uterine atony, which is the most prevalent cause of PPH, is still increasing in both vaginal delivery and caesarean section. "

02/01/2012 - "PPH, uterine atony, blood transfusion and morbidly adherent placenta. "
01/01/2011 - "Subjects with severe PPH secondary to uterine atony, who received a blood transfusion, were compared to matched controls. "
10/01/2015 - "Postpartum blood transfusion was required for symptomatic anemia because of uterine atony, and subsequent maternal and neonatal courses were uncomplicated. "
03/01/2012 - "Maternal outcomes included a composite (treated uterine atony, blood transfusion, and peripartum infections) and cesarean delivery. "
07/01/2004 - "By test of trend, only uterine atony (P <.01), maternal blood transfusion (P=.03), maternal admission to intensive care unit (P=.02), and 5-minute Apgar <or=3 (P <.01) were associated with duration of chorioamnionitis. "

07/01/2003 - "Uterine atony, 183 (53.8%) was the most common cause of PPH and a combination of uterotonic agents and uterine massage were effective in controlling PPH in 171 (49.1%) of the cases. "
06/01/2006 - "Totalling 112 puerperants with postpartum hemorrhage due to uterine atony were randomly assigned into 2 groups and received routine managements for uterine atony such as uterine massage and uterotonics administration. "
01/01/2005 - "Postpartum hemorrhage is most commonly due to uterine atony and often responds to medical treatments such as administration of uterotonic drugs, alone or in combination with uterine massage or bimanual compression. "
10/01/1991 - "Postpartum hemorrhage is most commonly due to uterine atony and often responds to medical treatments such as ecbolic medications, uterine massage or bimanual compression, and blood and fluid replacement. "
12/01/1995 - "Prostaglandins should be used as a second line treatment if uterine atony cannot be abolished by uterine massage and oxytocin infusion. "

02/01/2014 - "We conclude that uterine/vaginal balloon tamponade is very useful in the management of postpartum hemorrhage because of uterine atony and abnormal placentation."
06/01/2007 - "Thus balloon tamponade is an effective adjunct in the treatment of severe postpartum hemorrhage, especially when due to uterine atony when medical therapy fails."
11/01/2010 - "Management of post-partum haemorrhage (PPH) involves the treatment of uterine atony, evacuation of retained placenta or placental fragments, surgery due to uterine or birth canal trauma, balloon tamponade, effective volume replacement and transfusion therapy, and occasionally, selective arterial embolization. "
01/01/2014 - "Six (75%) of the 8 patients who were treated with B-Lynch brace suture for uterine atony and 9 (60%) of the 15 patients who were treated with the Bakri balloon tamponade system for uterine atony or placenta accreta required hysterectomy following the initial therapeutic measures. "